If GLP-1 Drugs Are Good For Everything, Should We All Be on Them?
derekthompson.org
If GLP-1 Drugs Are Good For Everything, Should We All Be on Them?
These approaches overlap, as we’ll see: reducing cardiovascular risk by targeting specific lipoproteins (cholesterol) may also reduce Alzheimer’s disease risk, for example, though not cancer. The steps we take to improve metabolic health and prevent type 2 diabetes almost certainly reduce the risk of cardiovascular disease, cancer, and Alzheimer’s
... See moreNew research shows that in humans, allulose has a favorable impact on blood glucose and may improve insulin sensitivity.